{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:50:10Z","timestamp":1791337810184,"version":"4.3.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jss.2026.05.082","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:57:07Z","timestamp":1786755427000},"page":"851-860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Disparities in Epidermal Growth Factor Receptor Mutation Testing for Non\u2013Small Cell Lung Cancer: Insights From the National Cancer Database"],"prefix":"10.1016","volume":"326","author":[{"given":"Akul","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2741-9241","authenticated-orcid":false,"given":"Amisha","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Barris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Sinopoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Tapias-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Towe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2026.05.082_bib1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41392-025-02243-6","article-title":"Advances in molecular pathology and therapy of non-small cell lung cancer","volume":"10","author":"Huang","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jss.2026.05.082_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyae357","article-title":"Emerging molecular testing paradigms in non-small cell lung cancer management\u2014current perspectives and recommendations","volume":"30","author":"Penault-Llorca","year":"2025","journal-title":"Oncologist"},{"key":"10.1016\/j.jss.2026.05.082_bib3","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/PO.20.00450","article-title":"Clinical utility of plasma-based comprehensive molecular profiling in advanced Non\u2013small-cell lung cancer","volume":"5","author":"Schouten","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jss.2026.05.082_bib4","doi-asserted-by":"crossref","first-page":"75712","DOI":"10.18632\/oncotarget.20095","article-title":"EGFR TKI as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer","volume":"8","author":"Nan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jss.2026.05.082_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41571-024-00971-2","article-title":"The changing treatment landscape of EGFR-mutant non-small-cell lung cancer","volume":"22","author":"Zhou","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jss.2026.05.082_bib6","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jiph.2012.09.008","article-title":"EGFR mutation testing in non-small cell lung cancer (NSCLC)","volume":"5","author":"Al Dayel","year":"2012","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jss.2026.05.082_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jmoldx.2013.03.001","article-title":"Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors","volume":"15","author":"Lindeman","year":"2013","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jss.2026.05.082_bib8","doi-asserted-by":"crossref","first-page":"610","DOI":"10.6004\/jnccn.2021.5020","article-title":"Non\u2013small cell lung cancer: recommendations for biomarker testing and treatment","volume":"19","author":"Aisner","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.jss.2026.05.082_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJMoa2304594","article-title":"Overall survival with osimertinib in resected EGFR -Mutated NSCLC","volume":"389","author":"Tsuboi","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2026.05.082_bib10","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in resected EGFR -Mutated Non\u2013small-cell lung cancer","volume":"383","author":"Wu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2026.05.082_bib11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1186\/s12913-022-07857-y","article-title":"Utilization and costs of epidermal growth factor receptor mutation testing and targeted therapy in medicare patients with metastatic lung adenocarcinoma","volume":"22","author":"Shen","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jss.2026.05.082_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101628","article-title":"Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe","volume":"8","author":"Hofman","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.jss.2026.05.082_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108412","article-title":"EGFR testing practices, treatment choice and clinical outcomes in advanced NSCLC in a real-world setting: a retrospective analysis of a US-based electronic health records database","volume":"201","author":"Subramanian","year":"2025","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jss.2026.05.082_bib14","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.21037\/jtd-20-3450","article-title":"Sociodemographic disparities in the management of advanced lung cancer: a narrative review","volume":"13","author":"Stein","year":"2021","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jss.2026.05.082_bib15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12885-018-4190-3","article-title":"Underutilization and disparities in access to EGFR testing among medicare patients with lung cancer from 2010 \u2013 2013","volume":"18","author":"Lynch","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jss.2026.05.082_bib16","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1158\/1055-9965.EPI-18-0917","article-title":"Disparities and trends in genetic testing and erlotinib treatment among metastatic non\u2013small cell lung cancer patients","volume":"28","author":"Palazzo","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jss.2026.05.082_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cllc.2019.07.003","article-title":"Survival disparities in black patients with EGFR-mutated non\u2013small-cell lung cancer","volume":"21","author":"Cheng","year":"2020","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jss.2026.05.082_bib18","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1080\/14796694.2024.2347826","article-title":"EGFR mutation testing, treatment and survival in stage I\u2013III non-small cell lung cancer: cancerlinq discovery database retrospective analysis","volume":"20","author":"Muthusamy","year":"2024","journal-title":"Future Oncol"},{"key":"10.1016\/j.jss.2026.05.082_bib19","article-title":"Real-world molecular testing rates and patterns in patients with primary advanced or recurrent endometrial cancer in the United States","volume":"9","author":"Chen","year":"2025","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jss.2026.05.082_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/jha2.16","article-title":"Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the connect\u00ae MDS\/AML disease registry","volume":"1","author":"Pollyea","year":"2020","journal-title":"eJHaem"},{"key":"10.1016\/j.jss.2026.05.082_bib21","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1186\/s12885-016-2812-1","article-title":"A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients","volume":"16","author":"Myers","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jss.2026.05.082_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/jpm6010008","article-title":"The changing landscape of molecular diagnostic testing: implications for academic medical centers","volume":"6","author":"Rehm","year":"2016","journal-title":"JPM"},{"key":"10.1016\/j.jss.2026.05.082_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.10809","article-title":"Practice-level variation in molecular testing and use of targeted therapy for patients with non\u2013small cell lung cancer and colorectal cancer","volume":"6","author":"Roberts","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jss.2026.05.082_bib24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cllc.2023.03.001","article-title":"Factors associated with receipt of molecular testing and its impact on time to initial systemic therapy in metastatic non-small cell lung cancer","volume":"24","author":"Osazuwa-Peters","year":"2023","journal-title":"Clin Lung Cancer"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480426004178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480426004178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:54:49Z","timestamp":1791334489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480426004178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"alternative-id":["S0022480426004178"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2026.05.082","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparities in Epidermal Growth Factor Receptor Mutation Testing for Non\u2013Small Cell Lung Cancer: Insights From the National Cancer Database","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2026.05.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}